Russian Journal of Child NeurologyRussian Journal of Child NeurologyРусский журнал детской неврологии2073-88032412-9178Publishing House ABV Press43010.17650/2073-8803-2023-18-1-10-21REVIEWS AND LECTURESОБЗОРЫ И ЛЕКЦИИClinical polymorphism of acute disseminated encephalomyelitis: diagnosis, treatment, long-term prognosis. Lecture with the description of clinical casesКлинический полиморфизм острого рассеянного энцефаломиелита: диагностика, лечение, отдаленный прогноз. Лекция с описанием клинических случаевAvdeevaV. E.АвдееваВ. Е.
Russian Federation

Varvara Evgenyevna Avdeeva

61/2 Shchepkina St., Moscow 129110

Варвара Евгеньевна Авдеева

129110 Москва, ул. Щепкина, 61/2

varvara-kitaeva@mail.ruKotovA. S.КотовА. С.
Russian Federation

61/2 Shchepkina St., Moscow 129110

129110 Москва, ул. Щепкина, 61/2

M. F. Vladimirsky Moscow Regional Research Clinical InstituteГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М. Ф. Владимирского»1501202318110212506202325062023Copyright ©; 2023, ABV-PressCopyright ©; 2023, АБВ-пресс2023ABV-PressАБВ-прессhttps://rjdn.abvpress.ru/jour/about/editorialPolicieshttps://rjdn.abvpress.ru/jour/article/view/430

Acute disseminated encephalomyelitis is an acute autoimmune demyelinating disease that manifests as a widespread polyfocal asymmetric lesions of the central nervous system and, in some cases, optic nerves with the formation of corresponding neurological symptoms. This lecture presents basic information about acute disseminated encephalomyelitis with consideration of 5 clinical cases demonstrating the variety of manifestations of this disease in the practice of a neurologist.

Острый рассеянный энцефаломиелит – это острое аутоиммунное демиелинизирующее заболевание, проявляющееся распространенным полиочаговым асимметричным поражением центральной нервной системы и, в некоторых случаях, оптических нервов с формированием соответствующих неврологических симптомов. В данной лекции представлены основные сведения об остром рассеянном энцефаломиелите с рассмотрением 5 клинических случаев, демонстрирующих многообразие проявлений этого заболевания в практике врача-невролога.

acute disseminated encephalomyelitismyelin oligodendrocyte glycoproteinmultiple sclerosisAQP-4острый рассеянный энцефаломиелитмиелин-олигодендроцитарный гликопротеинрассеянный склерозAQP-4Almaghrabi N., Saab A. Adult onset acute disseminated encephalomyelitis: A case report. Radiol Case Rep 2021;16(9):2469–73. DOI: 10.1016/j.radcr.2021.05.052Anilkumar A.C., Foris L.A., Tadi P. Acute Disseminated Encephalomyelitis. In: StatPearls. Treasure Island: StatPearls Publishing, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK430934/Ayed H., Chaudhary M.W., AlBaradie R., Mir A. Use of cyclophosphamide in a child with fulminant acute disseminated encephalomyelitis. Child Neurol Open 2018;5:2329048X18754631. DOI: 10.1177/2329048X18754631Boesen M.S., Langkilde A.R., Ilginiene J. et al. Oligoclonal bands, age 11-17 years, occipital lesion, and female sex differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort study. Mult Scler Relat Disord 2022;66:104008. DOI: 10.1016/j.msard.2022.104008Hyun J.W., Huh S.Y., Shin H.J. et al. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis. Mult Scler 2019;25(4):585–90. DOI: 10.1177/1352458518761186Iype M., Kunju M., Saradakutty G. et al. Short term outcome of ADEM: Results from a retrospective cohort study from South India. Mult Scler Relat Disord 2017;18:128–34. DOI: 10.1016/j.msard.2017.09.018Jarius S., Paul F., Aktas O. et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018;15(1):134. DOI: 10.1186/s12974-018-1144-2Kawanaka Y., Ando K., Ishikura R. et al. Delayed appearance of transient hyperintensity foci on T1-weighted magnetic resonance imaging in acute disseminated encephalomyelitis. Jpn J Radiol 2019;37(4):277–82. DOI: 10.1007/s11604-018-00808-wKetelslegers I.A., Visser I.E., Neuteboom R.F. et al. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler 2011;17(4):441–8. DOI: 10.1177/1352458510390068Kunchok A., Zekeridou A., McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 2019;32(3):452–8. DOI: 10.1097/WCO.0000000000000676López-Chiriboga A.S., Majed M., Fryer J. et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgGassociated disorders. JAMA Neurol 2018;75(11):1355–63. DOI: 10.1001/jamaneurol.2018.1814Mahapure K.S., Prabhune A.S., Chouvhan A.V. COVID-19-associated acute disseminated encephalomyelitis: A systematic review. Asian J Neurosurg 2021;16(3):457–69. DOI: 10.4103/ajns.AJNS_406_20Makuuchi Y., Nishimoto M., Yamamoto K. et al. Successful treatment with rituximab in acute disseminated encephalomyelitis with whole spinal cord involvement following HLA haploidentical transplantation. Rinsho Ketsueki 2018;59(12):2588–93. DOI: 10.11406/rinketsu.59.2588Manzano G.S., McEntire C.R.S., Martinez-Lage M. et al. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: Systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021;8(6):e1080. DOI: 10.1212/NXI.0000000000001080Massa S., Fracchiolla A., Neglia C. et al. Update on acute disseminated encephalomyelitis in children and adolescents. Children (Basel) 2021;8(4):280. DOI: 10.3390/children8040280Mikaeloff Y., Caridade G., Husson B. et al. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2007;11(2):90–5. DOI: 10.1016/j.ejpn.2006.11.007Narayan R., Simpson A., Fritsche K. et al. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 2018;25:66–72. DOI: 10.1016/j.msard.2018.07.025Narayan R.N., Wang C., Greenberg B.M. Acute disseminated encephalomyelitis (ADEM) and increased intracranial pressure associated with anti-myelin oligodendrocyte glycoprotein antibodies. Pediatr Neurol 2019;99:64–8. DOI: 10.1016/j.pediatrneurol.2019.03.009Paolilo R.B., Deiva K., Neuteboom R. et al. Acute disseminated encephalomyelitis: Current perspectives. Children (Basel) 2020;7(11):210DOI: 10.3390/children7110210Pohl D., Alper G., Van Haren K. et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology 2016;87(9 Suppl 2):S38–S45. DOI: 10.1212/WNL.0000000000002825Pruss H. Autoantibodies in neurological disease. Nat Rev Immunol 2021;21(12):798–813. DOI: 10.1038/s41577-021-00543-wThompson A.J., Banwell B.L., Barkhof F. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17(2):162–73. DOI: 10.1016/S1474-4422(17)30470-2Vogrig A., Janes F., Gigli G.L. et al. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg 2021;208:106839. DOI: 10.1016/j.clineuro.2021.106839Wang C.X. Assessment and management of acute disseminated encephalomyelitis (ADEM) in the pediatric patient. Paediatr Drugs 2021;23(3):213–21. DOI: 10.1007/s40272-021-00441-7Wingerchuk D.M., Banwell B., Bennett J.L. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177–89. DOI: 10.1212/WNL.0000000000001729Yamamoto D., Uchiyama T., Ohashi T., Iizuka T. Case of steroidresponsive unilateral encephalitis with anti-myelin oligodendrocyte glycoprotein antibodies. Neurol Clin Neurosci 2017;5(3):101, 102. DOI: 10.1111/ncn3.12119Yanagida A., Iizuka T., Nagai T. et al. MOG-IgG-positive multifocal myelitis with intrathecal IgG synthesis as a spectrum associated with MOG autoimmunity: two case reports. J Neurol Sci 2017;382:40–3. DOI: 10.1016/j.jns.2017.09.020Zghali M.G. Tumefactive acute disseminated encephalomyelitis. Neurol India 2020;68(1):35–41. DOI: 10.4103/0028-3886.279688